Constellium 10-Q: Q3 Net Income $119M, EPS $0.84; ABL Upsized to $700M
CSTM sits 67% above its 52-week low of $14.62.
Summary
Constellium's Q3 10-Q confirms $119 million of net income ($0.84 per diluted share) and shows the Pan-U.S. ABL upsized to $700 million with maturity extended to 2031, alongside a completed Ravenswood pension settlement.
Key Events · Earnings and Guidance · CSTM
-
Q3 Net Income $119M, EPS $0.84
Revenue of $2,639 million produced net income of $119 million, or $0.84 per diluted share, versus $88 million and $0.62 a year earlier; nine-month net income reached $463 million against $162 million.
-
P&ARP Drives Segment EBITDA to $280M
Segment Adjusted EBITDA was $280 million: P&ARP $162 million (up 98% on favorable metal costs and price/mix), A&T $102 million, AS&I $21 million (down 36% against a 2025 customer compensation benefit).
-
ABL Upsized to $700M, Maturity 2031
The October 22, 2026 amendment raised Pan-U.S. ABL commitments from $550 million to $700 million and extended maturity to October 22, 2031; total liquidity was $992 million at quarter-end.
-
Ravenswood Pension Plan Settled
The Ravenswood salaried pension plan was settled through lump sums and an annuity purchase, derecognizing $47 million of pension obligations and $44 million of plan assets.
Analysis · CSTM · Manufacturing
Full statements in the 10-Q back up the same-day earnings release: Q3 net income of $119 million ($0.84 diluted EPS) and nine-month net income of $463 million versus $162 million a year earlier. Profit for the quarter was driven by P&ARP, where Segment Adjusted EBITDA nearly doubled to $162 million on favorable metal costs and price/mix; by contrast, AS&I fell 36% to $21 million against a tough 2025 comparison that included a customer compensation payment. Beyond the headline numbers, two balance-sheet items stand out. The Pan-U.S. ABL was amended on October 22 to raise commitments from $550 million to $700 million and push maturity to 2031, and the Ravenswood salaried pension plan was settled, removing $47 million of obligations. Liquidity stands at $992 million, and the company kept buying back stock, repurchasing 1,044,441 shares for $30 million in the quarter with $257 million left on the program.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CSTM was trading at $24.38 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $14.62 to $36.99. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.